Related Experiment Video
Updated: Apr 6, 2026
09:28
Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
Published on: May 18, 2020
9.4K
Halal pharmaceutical industry: opportunities and challenges.
Mohd Nor Norazmi1, Li Sze Lim2
1School of Health Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia; Institute for Research in Molecular Medicine, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia.
Trends in Pharmacological Sciences
|July 19, 2015
Summary
The growing Muslim population drives demand for halal pharmaceuticals. Establishing a regulated, harmonized halal management and accreditation system is crucial for this industry
Area of Science:
- Pharmaceutical Sciences
- Islamic Studies
- Business Management
Background:
- Increasing global Muslim population fuels demand for halal-compliant products.
- The pharmaceutical sector faces unique challenges in meeting these specific religious and ethical requirements.
- Existing supply chains and manufacturing processes require adaptation for halal certification.
Purpose of the Study:
- To identify key challenges in the halal pharmaceutical industry.
- To emphasize the need for a standardized accreditation and management system.
- To explore strategies for developing a robust halal pharmaceutical ecosystem.
Main Methods:
- Literature review of existing halal standards and pharmaceutical regulations.
- Analysis of market trends and consumer demand for halal pharmaceuticals.
- Case study examination of current halal certification processes.
Main Results:
- Significant demand exists for halal pharmaceuticals globally.
- Lack of a harmonized accreditation system is a major barrier.
- Need for clear guidelines and regulatory frameworks for manufacturers and consumers.
Conclusions:
- A well-regulated and harmonized halal management and accreditation system is essential for industry growth.
- Collaboration between regulatory bodies, industry stakeholders, and Islamic scholars is vital.
- Addressing these challenges will unlock the potential of the halal pharmaceutical market.
Related Concept Videos
01:30Production of Pharmaceuticals
65
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
65
01:03Drug Control Governance: Regulatory Bodies and Their Impact
659
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
659
01:25Drug Regulation
3.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.3K
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
226
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
226
01:28Drug Products: Biologics, Biosimilars and Interchangeables
353
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
353
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
216
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
216